1. Immunology/Inflammation
  2. TREM receptor
  3. AL002

AL002 is a humanized monoclonal IgG1 antibody and a blood-brain barrier-permeable TREM2 modulator. AL002 binds to TREM2 on the surface of microglia, promotes TREM2 clustering and the formation of the TREM2-DAP12 complex, activates the TREM2 signaling pathway and PI3K cascade, and induces TREM2 internalization and degradation. AL002 is applicable to research related to Alzheimer's disease.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

AL002

AL002 構造式

容量 価格(税別) 在庫状況 数量
>無料サンプル (100 μg)   今すぐ申し込む  
1 mg $360 在庫あり
5 mg $1080 在庫あり
10 mg $1700 在庫あり
50 mg   お問い合わせ  
100 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

TREM receptor アイソフォーム固有の製品をすべて表示:

  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

AL002 is a humanized monoclonal IgG1 antibody and a blood-brain barrier-permeable TREM2 modulator. AL002 binds to TREM2 on the surface of microglia, promotes TREM2 clustering and the formation of the TREM2-DAP12 complex, activates the TREM2 signaling pathway and PI3K cascade, and induces TREM2 internalization and degradation. AL002 is applicable to research related to Alzheimer's disease[1][2].

Isotype

Human IgG1 kappa

Recommend Isotype Controls
Species Reactivity

Human

IC50 & Target

TREM-2

 

体外実験

AL002 (0.0003-5 μg/mL, 48 h) reduces membrane-bound and soluble TREM2 levels in primary human macrophages, indicating TREM2 activation and internalization[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Parmacokinetics
Species Dose Route Cmax AUC0-t CL
Cynomolgus Monkey[1] 20 mg/kg i.v. 504 μg/mL 33,700 μg·h/mL 0.615 mL/h/kg
Cynomolgus Monkey[1] 80 mg/kg i.v. 1560 μg/mL 99,400 μg·h/mL 0.811 mL/h/kg
Cynomolgus Monkey[1] 250 mg/kg i.v. 5130 μg/mL 265,000 μg·h/mL 0.976 mL/h/kg
体内実験

AL002 (20-250 mg/kg; i.v.; once weekly or once monthly) dose-dependently engages TREM2 and activates downstream signaling pathways in healthy cynomolgus monkeys, with the 250 mg/kg weekly dose producing the most robust reductions in CSF sTREM2 and brain total TREM2, and increases in SPP1, CSF1R, and IL1RN[1].
AL002c (50 mg/kg; single dose) upregulates genes associated with TREM2 signaling in the frontal cortex of human TREM2-overexpressing transgenic mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Cambodia origin cynomolgus monkeys (24 to 50 months old, male/female); naive female cynomolgus monkeys (2-3 kg)[1]
Dosage: 20 mg/kg; 80 mg/kg; 250 mg/kg
Administration: i.v.; once weekly (5 doses for 4-week study; 3 doses for DRF study); once monthly (3 doses for interval study); 4-week recovery period for 250 mg/kg group
Result: Dose-dependently decreased CSF sTREM2: 20 mg/kg caused a partial reduction, while 80 and 250 mg/kg caused >70% reduction compared with predose levels.\nDose-dependently reduced total TREM2 protein in brain tissues: 250 mg/kg significantly reduced TREM2 in frontal cortex (p < 0.001) and hippocampus (p < 0.0001); 80 mg/kg significantly reduced TREM2 in hippocampus (p < 0.001); 20 mg/kg showed a non-significant reduction trend.\nDose-dependently increased frontal cortex SPP1 mRNA expression: 80 and 250 mg/kg had significantly higher levels than controls (ps < 0.01).\nElevated CSF SPP1 protein levels: 80 and 250 mg/kg showed increases 48 hours after Day 1 dose; 250 mg/kg caused statistically significant increases 12 and 24 hours after each monthly dose; 80 mg/kg showed partial, non-significant increases after monthly doses.\nIncreased frontal cortex CSF1R mRNA and protein: 250 mg/kg had significantly elevated CSF1R mRNA and protein (p < 0.05) compared with controls; lower doses showed non-significant trends.\nElevated CSF IL1RN protein levels: 80 and 250 mg/kg had significantly higher levels 48 hours after Day 1 dose and 48 hours after Day 29 dose (ps < 0.0001).
Animal Model: BAC transgenic mice overexpressing human TREM2[1]
Dosage: 50 mg/kg
Administration: single dose
Result: Upregulated expression of Tyrobp (Dap12), Csf1r, and Gfap genes in frontal cortex.
Gene ID

54209  [NCBI]

Accession
Application

ELISA, FACS, Functional assay

Conjugated

Unconjugated

Reconsititution

The product can be reconstituted/diluted with sterile PBS or saline.

分子量

145.62 kDa

Appearance

Liquid

Color

Colorless to light yellow

SMILES

[AL002]

輸送条件

Shipping with dry ice.

Formulation

Please refer to the lot-specific COA for specific buffer information.

保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション
参考文献
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
AL002
製品番号:
HY-P991220
数量:
MCE 日本正規代理店: